Skip to main content
. Author manuscript; available in PMC: 2023 Jan 15.
Published in final edited form as: Int J Cancer. 2021 Oct 5;150(2):279–289. doi: 10.1002/ijc.33810

Table 2. Results of the association between SNPs and OS as a prognostic effect and as a predictive effect. Ten most statistically significant SNPs associated with OS with same direction of effect (either reduced or increased OS), in at least three out of four trials.

Rows in bold are those with p-value<0.05 in at least three out of four trials. Ch chromosome, NA Intergenic SNP, MAF minor allele frequencies in CALGB 80303, 40503, 80405, and ICON7, respectively, HR hazard ratio, CI confidence interval. Direction of effect increasing (−) or decreasing (+) OS in CALGB 80303, 40503, 80405, and ICON7, respectively. “_” SNP not present in the genotyping platform of the trial.

Prognostic effect

SNP Ch Gene Feature 5’ flanking 3’ flanking Base change MAF Direction of effect Effect size (β) HR (95% CI) p-value

rs680949 9 PRUNE2 intron LOC392352 LOC392352 A>G 0.07/0.06/0.07/0.06 ++++ 0.45 1.57 (1.33– 1.86) 1.02x10 −7
rs218527 18 NA NA LOC100129774 LOC100128360 G>A 0.09/0.10/0.10/0.11 ++++ 0.39 1.48 (1.28–1.71) 1.83x10 −7
rs2795492 9 CORO2A intron TRIM14 TBC1D2 G>A 0.41/0.41/0.42/0.42 ---- −0.22 0.81 (0.73–0.88) 5.41x10−6
rs476612 9 LOC100129762 intron LOC392352 PRUNE2 A>C _/0.06/0.07/0.06 _+++ 0.52 1.68 (1.34–2.12) 8.45x10 −6
rs7615734 3 NA NA TPRG1 TP63 A>G 0.16/0.18/0.18/0.21 ++++ 0.26 1.29 (1.15–1.45) 9.58x10−6
rs6712389 2 NA NA KIAA1604 LOC729009 G>A _/0.31/0.29/0.27 _--- −0.28 0.76 (0.67–0.86) 1.16x10−5
rs16852804 2 BARD1 intron LOC100128203 ABCA12 G>A 0.06/0.10/0.07/0.06 ++++ 0.41 1.51 (1.25–1.82) 1.40x10−5
rs10950639 7 NA NA AGR3 LOC100131425 A>G _/0.17/0.21/0.20 _+++ 0.29 1.33 (1.17–1.52) 1.40x10−5
rs4807493 19 PIP5K1C UTR-3’ C19orf29 TJP3 G>A 0.21/0.17/0.18/0.20 -+-- −0.25 0.78 (0.70–0.88) 2.26x10−5
rs2103445 8 NA NA CALB1 TMEM64 G>A _/0.30/0.29/0.31 _+++ 0.25 1.29 (1.15–1.45) 2.29x10−5

Predictive effect

SNP Ch Gene Feature 5’ flanking 3’ flanking Base change MAF Direction of effect Effect size (β) p-value

rs4969481 17 DCXR near 3’ RAC3 DCXR G>A 0.13/0.16/0.14/0.14 ---- −0.70 1.18x10−7
rs11895736 2 LTBP1 intron TTC27 RASGRP3 A>G 0.12/0.14/0.14/0.14 ---- −0.68 6.85x10−7
rs448960 20 LOC100129869 near 3’ PMEPA1 LOC100129869 A>G _/0.49/0.46/0.47 _--- −0.58 7.50x10−6
rs10763269 10 NA NA LOC389970 ZWINT G>A 0.27/0.24/0.22/0.21 ++++ 0.48 1.09x10−5
rs13392750 2 NA NA ANKRD44 LOC729342 A>G _/0.46/0.46/0.43 _+++ 0.58 1.23x10−5
rs3795897 2 AGAP1 intron LOC642692 LOC100130154 G>A 0.13/0.11/0.17/0.13 ++++ 0.68 1.43x10 −5
rs1150743 6 NA NA HLA-J ETF1P1 G>A 0.11/0.11/0.10/0.10 ++++ 0.66 1.83x10−5
rs10915428 1 NA NA hCG_2036596 LOC644357 A>C 0.46/0.44/0.51/0.48 ---- −0.39 1.86x10−5
rs11860804 16 NA NA LOC729847 DYNLRB2 G>A _/0.49/0.50/0.49 _--- −0.49 1.87x10−5
rs6453031 5 RGNEF intron UTP15 ENC1 A>C _/0.15/0.16/0.16 _--- −0.63 1.88x10−5